Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
25.32
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Today 8:03 EDT
Via
Benzinga
Is Pfizer Stock a Yield Trap?
Today 4:21 EDT
Via
The Motley Fool
Topics
Intellectual Property
3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 9% -- Which Make for No-Brainer Buys in July
Today 3:51 EDT
Three supercharged dividend stocks have the necessary catalysts to make their patient shareholders notably richer.
Via
The Motley Fool
Topics
Bonds
Economy
CDC Greenlights Vaccines From Pfizer, Moderna, GSK Amid Shakeup Of Advisory Panel
July 02, 2025
The agency expanded its RSV and meningococcal vaccine guidance to cover younger age groups and new formulations.
Via
Stocktwits
Topics
Government
Huge Unusual Volume In Pfizer Put Options Signals Investors Bullish Outlook
July 02, 2025
Large unusual trading volume in Pfizer, Inc. put options that expire 30 days from now signals investors' bullish outlook on PFE stock.
Via
Talk Markets
Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons
July 02, 2025
Via
Benzinga
2 of Wall Street’s Favorite Stocks to Research Further and 1 to Question
July 02, 2025
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...
Via
StockStory
Curious about the most active S&P500 stocks in today's session?
July 01, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active S&P500 stocks in today's session.
Via
Chartmill
Dynamic Global Events Presents: The 6th Clinical Trial Agreements Summit
July 01, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Ex-Pfizer Exec Pulled Into House Probe Over Alleged COVID Vaccine Delay Through 2020 Election
June 30, 2025
The committee cited remarks allegedly made by Philip Dormitzer at GSK, claiming that Pfizer’s top R&D leaders delayed clinical trial progress to avoid releasing results before the 2020 election.
Via
Stocktwits
Topics
Government
Law Enforcement
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
June 30, 2025
The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide.
Via
Investor's Business Daily
3 No-Brainer Stocks to Buy for Under $100 Right Now
June 28, 2025
Via
The Motley Fool
Topics
Intellectual Property
CDC Vaccine Panel Overhauled by RFK Jr. Votes To Drop Mercury Preservative, Critics Sound Alarm
June 26, 2025
The panel also voted to recommend Merck’s RSV antibody drug Enflonsia for newborns whose mothers didn’t receive prenatal protection.
Via
Stocktwits
Pfizer Seeks Label Expansion For Hemophilia Drug After Promising Data
June 26, 2025
Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and showing good tolerability.
Via
Benzinga
Tesla Senior Executive And Elon Musk Confidant Omead Afshar Leaves EV Giant Amid Dropping Sales, Days After Robotaxi Launch: Report
June 26, 2025
Afshar was promoted last year to oversee sales and manufacturing operations in North America and Europe. He previously worked in the office of the CEO.
Via
Stocktwits
Topics
Artificial Intelligence
Pfizer’s Hemophilia Drug Meets Goals In Late-Stage Trial In Patients With Certain Antibodies
June 26, 2025
During the study, 48 people living with hemophilia were treated with Hympavzi and observed to have a 93% reduction in annualized bleeding rate in 12 months.
Via
Stocktwits
Topics
Death
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors
June 26, 2025
From
Pfizer Inc.
Via
Business Wire
RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group
June 26, 2025
Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel is facing criticism from medical experts.
Via
Benzinga
Moderna, Pfizer, Novavax Draw Bearish Buzz Ahead Of CDC Panel With Vaccine Skeptics
June 25, 2025
RFK Jr.'s newly appointed CDC panel, half of whom oppose vaccines, prepares to review key data on COVID, RSV, and flu shots.
Via
Stocktwits
Pfizer Declares Third-Quarter 2025 Dividend
June 25, 2025
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts
June 25, 2025
From
Pfizer Inc.
Via
Business Wire
3 Reasons PFE is Risky and 1 Stock to Buy Instead
June 25, 2025
Over the past six months, Pfizer’s shares (currently trading at $24.29) have posted a disappointing 8.5% loss while the S&P 500 was flat. This may have investors wondering how to approach the...
Via
StockStory
Topics
Stocks
My 5 Favorite Dirt Cheap Stocks to Buy Right Now
June 24, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
World Trade
10 Stocks That Pay $100 or More in Dividends
June 23, 2025
Via
The Motley Fool
Topics
Economy
2 S&P 500 Stocks on Our Watchlist and 1 to Think Twice About
June 23, 2025
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...
Via
StockStory
Topics
Stocks
The 5 Most Interesting Analyst Questions From Pfizer’s Q1 Earnings Call
June 23, 2025
Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined expense control, even as revenue declined. CEO Albert Bourla credited robust...
Via
StockStory
Topics
Earnings
World Trade
Smart Money is Quietly Loading Up On This $160M Oncology Stock — Is Nuvectis Pharma the Next Breakout Biotech? (NASDAQ: NVCT)
June 20, 2025
With clinical catalysts on the horizon and a seasoned biotech insider doubling down, Could Nuvectis Pharma (NASDAQ:NVCT)* Become the Next Summit Therapeutics (NASDAQ: SMMT)?
Via
News Direct
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
June 20, 2025
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
Via
Benzinga
1 Large-Cap Stock to Research Further and 2 to Turn Down
June 20, 2025
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...
Via
StockStory
Curious about the most active S&P500 stocks in today's session?
June 18, 2025
Looking for the most active stocks in the S&P500 index on Wednesday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.